Cellectis SA (CLLS)
3.03
-0.03
(-0.98%)
USD |
NASDAQ |
Jun 08, 15:38
Cellectis Market Cap : 304.82M for June 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| DBV Technologies SA | 942.78M |
| Akari Therapeutics Plc | 17.95M |
| Amarin Corp. Plc | 297.91M |
| Grifols SA | 1.903B |
| Autolus Therapeutics Plc | 384.60M |
Market Cap Related Metrics
| PS Ratio | 4.478 |
| PEG Ratio | -0.4299 |
| Price to Book Value | 5.087 |
| Price | 3.03 |
| Earnings Yield | -22.23% |
| PEGY Ratio | -0.4299 |